Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain flag Spain · Delayed Price · Currency is EUR
61.50
+0.70 (1.15%)
Aug 27, 2026, 5:35 PM CET

BME:ROVI Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
773.05743.48763.75829.51817.7648.68
Revenue Growth
3.21%-2.65%-7.93%1.44%26.06%54.46%
Gross Profit
500.42471.59467.71483.34512.43379.84
Operating Income
150.85173.14178.71219.47253.74180.15
Net Income
185.18140.44136.88170.34199.67153.08
Earnings Per Share
3.622.752.673.203.732.76
EPS Growth
39.93%2.73%-16.53%-14.25%35.31%150.36%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Manufacturing
513.22494.13600.35644.41619.23471.79
Other
0.140.1----
Inter-Segment Transactions
-214.59-224.63-264.13-235.13-215.69-207.09
Marketing
474.29473.89427.53420.23414.15383.98
Total
773.05743.48763.75829.51817.7648.68

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
128.0798.628.0225.44125.0399.14
Total Debt
107.69121.82114.4165.4372.1773.16
Net Cash (Debt)
20.38-23.22-86.39-39.9952.8725.97
Net Cash Growth
----103.55%-
Net Cash Per Share
0.40-0.45-1.69-0.750.990.47

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
253.32187.08138.28113.25237.6149.44
Capital Expenditures
-73.93-65.21-59.12-53.79-50.72-40.22
Free Cash Flow
179.39121.8779.1659.45186.88109.22
Free Cash Flow Growth
138.23%53.95%33.15%-68.19%71.10%1348.77%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
64.73%63.43%61.24%58.27%62.67%58.55%
Operating Margin
19.51%23.29%23.40%26.46%31.03%27.77%
Pretax Margin
30.43%24.65%23.27%26.57%31.55%28.15%
Profit Margin
23.96%18.89%17.92%20.53%24.42%23.60%
FCF Margin
23.21%16.39%10.37%7.17%22.86%16.84%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.9590.9590.9351.1041.2940.956
Dividend Per Share Growth
2.60%2.60%-15.28%-14.69%35.39%150.68%
Dividend Yield
1.65%1.53%1.53%1.91%3.82%1.40%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
16.7923.1323.5218.869.6427.03
Forward PE
20.8121.5819.0219.7612.7625.70
P/FCF Ratio
17.3326.6540.6854.0410.3037.89
PS Ratio
4.024.374.223.872.356.38